Patient Deaths and Data Shortfall Spell the End for Cell Therapy Biotech Artiva

Artiva Biotherapeutics attributed one of many fatalities to a drug used to arrange sufferers for cell remedy and to not the cell remedy itself. However Artiva’s setbacks observe security alerts reported for autoimmune illness cell remedy packages from Novartis and Bristol Myers Squibb.

The put up Affected person Deaths and Knowledge Shortfall Spell the Finish for Cell Remedy Biotech Artiva appeared first on MedCity Information.

Source link